Edward M Basile Trans Medics Group, Inc. (TMDX) insider trading activity

Edward M Basile is of TransMedics Group, Inc.. Currently has a direct ownership of 2,866 shares of TMDX, which is worth approximately $329,618. The most recent transaction as insider was on Oct 29, 2025, when has been sold 4,142 shares (Common Stock) at a price of $130.45 per share, resulting in proceeds of $540,323. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.87K

0% 3M change

291.53% 12M change

Total Value Held $329,618

Edward M Basile Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 29 2025	SELL Open market or private sale	$540,323 $130.45 p/Share	4,142 Reduced 59.1%	2,866 Common Stock
Oct 29 2025	BUY Exercise of conversion of derivative security	$2,899 $0.7 p/Share	4,142 Added 37.15%	7,008 Common Stock
Aug 04 2025	SELL Open market or private sale	$519,987 $125.51 p/Share	4,143 Reduced 59.11%	2,866 Common Stock
Aug 04 2025	BUY Exercise of conversion of derivative security	$2,900 $0.7 p/Share	4,143 Added 37.15%	7,009 Common Stock
May 27 2025	SELL Open market or private sale	$632,250 $126.45 p/Share	5,000 Reduced 63.56%	2,866 Common Stock
May 27 2025	BUY Exercise of conversion of derivative security	$3,500 $0.7 p/Share	5,000 Added 38.86%	7,866 Common Stock
May 22 2025	BUY Grant, award, or other acquisition	-	2,134 Added 42.68%	2,866 Common Stock

May 09 2025	SELL Open market or private sale	$693,780 $115.63 p/Share	6,000 Reduced 89.13%	732 Common Stock
May 09 2025	BUY Exercise of conversion of derivative security	$4,200 $0.7 p/Share	6,000 Added 47.13%	6,732 Common Stock
Nov 05 2024	SELL Open market or private sale	$565,852 $83.83 p/Share	6,750 Reduced 90.22%	732 Common Stock
Nov 05 2024	BUY Exercise of conversion of derivative security	$189,810 $28.12 p/Share	6,750 Added 47.43%	7,482 Common Stock
Aug 06 2024	SELL Open market or private sale	$1,013,444 $150.14 p/Share	6,750 Reduced 90.22%	732 Common Stock
Aug 06 2024	BUY Exercise of conversion of derivative security	$189,810 $28.12 p/Share	6,750 Added 47.43%	7,482 Common Stock
Jun 05 2024	SELL Open market or private sale	$164,729 $138.08 p/Share	1,193 Reduced 61.97%	732 Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	732 Added 27.55%	1,925 Common Stock
May 07 2024	SELL Open market or private sale	$933,559 $130.44 p/Share	7,157 Reduced 85.71%	1,193 Common Stock
Feb 06 2024	SELL Open market or private sale	$619,438 $86.55 p/Share	7,157 Reduced 46.15%	8,350 Common Stock
May 25 2023	BUY Grant, award, or other acquisition	-	1,193 Added 7.14%	15,507 Common Stock
Mar 01 2023	SELL Open market or private sale	$280,350 $80.1 p/Share	3,500 Reduced 19.65%	14,314 Common Stock
Feb 27 2023	SELL Open market or private sale	$389,600 $77.92 p/Share	5,000 Reduced 21.92%	17,814 Common Stock

EMB

Edward M Basile

Andover, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TMDX shares.

Notify only if

Value

Insider Trading

Get notified when an Trans Medics Group, Inc. insider buys or sells TMDX shares.

Notify only if

Operation

Value

Type

News

Receive news related to TransMedics Group, Inc.

Track Activities on TMDX

Account